JACQUELINE GAFFNEY: Open Payments
NPI 1427055334 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 8 payments from 7 companies in 2025. Trend: 2023 $487 · 2024 $318 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 2 | $45 |
| Galderma Laboratories, L.P. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| LNHC, Inc | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Botanix SB Inc | 1 | $16 |
| UCB, Inc. | 1 | $15 |
Products named: ADBRY, NEMLUVIO, DUPIXENT, ZELSUVMI, SOFDRA, Bimzelx.
Industry payments across NE — which companies pay providers there.
